Total Company Revenues of $425.5 Million for the Second Quarter of 2026— —BRINSUPRI®(brensocatib) Revenues of $309.2 Million for the Second Quarter of 2026, Reflecting 49% Growth Over the First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results